Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
about
Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytomaAre all n-3 polyunsaturated fatty acids created equal?The tetraspan protein EMP2 regulates expression of caveolin-1.Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancerAnalysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissuesIdentification of a new target region on the long arm of chromosome 7 in gastric carcinoma by loss of heterozygosity.TGF-β mediated DNA methylation in prostate cancer.Epigenetic changes in prostate cancer: implication for diagnosis and treatment.Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.Epigenetics of prostate cancer: beyond DNA methylationEpigenetic analysis of laser capture microdissected fetal epitheliaCytogenetics and molecular genetics of cancer of the prostate.Interaction among Caveolin-1 genotypes (rs3807987/rs7804372), H. pylori infection, and risk of gastric cancer in a Chinese population.Aberrant DNA methylation and prostate cancer.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Epigenetic modifications of caveolae associated proteins in health and disease.Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasiaIs caveolin-1 a viable therapeutic target to reduce cancer metastasis?Lipid rafts and caveolae in signaling by growth factor receptors.Caveolin-1: a marker for pancreatic cancer diagnosis.Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines.The role of caveolin-1 in prostate cancer: clinical implications.Promoter hypermethylation in prostate cancer.Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators.Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.Frequent hypermethylation of the RASSF1A gene in prostate cancer.Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells.Caveolin-1 expression is maintained in rat and human astroglioma cell lines.Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid.DNA methylation in promoter region as biomarkers in prostate cancer.Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis.
P2860
Q24795636-50719677-B370-4F75-BBDA-91ED1F223011Q27497371-419435D8-698C-428F-AB83-70EEB0034212Q33289837-0C668A3A-89E9-46E4-B410-1B3935A748FEQ33381372-7ED55615-1335-42BB-A6DE-2742D5E2A484Q33400947-ACE58AE2-7F9F-4247-8521-10264E80A24CQ33868902-24D73529-651E-4729-B2CD-DE415A76FB48Q34039935-70B76014-D07C-4106-9C8F-B2607D39CDE2Q34385658-62BBF54B-06CC-4798-8468-9F868C6365BEQ34417941-B54AF577-70BD-44E7-946B-D5EED3579EF7Q34505232-F5BC511D-DF50-49B8-B629-2B04C97B3CDAQ34890656-78E7FC08-F61D-4EBD-A785-677ED3C149FCQ34984193-332B4AB4-E5E0-4527-9B17-DE749C95B101Q34996719-74EAD5A8-EE39-4F44-9312-DA661BBE09A2Q35560819-F0878ACE-BD73-45D7-B674-4F2214DB0F3BQ35636543-E4ADF084-5946-4D2D-B16B-44DB894E606CQ35674847-52490F5C-53C5-4354-9218-473DFC8CE380Q35789293-942EA98B-DF51-48A6-ABB8-0F3E4CB456D8Q36596684-053609C8-B613-45BA-A1C7-EE40970A5FF6Q36944094-6D5BFA06-14AB-416B-9034-DA016BC0749DQ37206243-36A9B208-1742-470E-BCC1-7825D8DBC04DQ37281690-74D32230-BB02-4418-B56B-80EFB740B940Q37542947-D388DDFE-D093-433C-8305-014284980479Q37791396-5223AC05-7624-41F4-AA9F-EB5B33EB6838Q38128481-2756754C-6D9D-4562-9081-CA7464379469Q38689014-37D819ED-41D1-4946-B114-776463D10223Q38959475-7F2AA097-F65D-4948-BEED-37BB97D6149CQ39237435-FB25691F-88AF-4E99-B22A-E25D49520748Q40700144-5470685F-A6DC-4685-BBBE-BC773ADC077CQ40715796-50FE1BE1-FE5A-4B9E-840B-3DA99E9B7B1CQ40749203-3F973BFA-801A-4523-9138-5A539024A5AFQ40809878-4A0A78EA-AAB7-4829-8C9F-C7777806C4D0Q41861416-BDC2475B-D8BC-418F-ADBB-AF577B07087AQ42261678-3D665E7D-CAA1-400C-90A6-67278DC263ACQ42558314-D6A5E1CD-E8A9-4FBC-9C17-14BE6A03960EQ47323579-29FA0F06-0323-4D15-B395-0B0BADB56D57
P2860
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
@ast
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
@en
type
label
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
@ast
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
@en
prefLabel
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
@ast
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
@en
P2093
P2860
P1433
P1476
Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
@en
P2093
P2860
P304
P356
10.1002/1097-0045(20010215)46:3<249::AID-PROS1030>3.0.CO;2-#
P577
2001-02-01T00:00:00Z